127168-91-6Relevant articles and documents
2-CYANOISOINDOLINE DERIVATIVES FOR TREATING CANCER
-
Page/Page column 60, (2017/10/11)
The invention relates to novel compounds of formula I which are inhibitors of deubiquitylating enzymes (DUBs) and/or desumoylating enzymes. In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase 7 or ubiquitin specific peptidase 7 (USP7). The invention further relates to methods for the preparation of these compounds and to their use in the treatment of cancer.
AMIDE RESORCINOL COMPOUNDS
-
Page/Page column 55, (2008/12/05)
The present invention is directed to amide resorcinol compounds and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as HSP-90 inhibitors.
Synthesis of Substrate Analogues and Inhibitors for the Phosphoglycerate Mutase Enzyme
Puyau, P. de Macedo,Perie, J. J.
, p. 13 - 46 (2007/10/03)
Several substrate analogues of the title enzyme were synthesized as well as with possible irreversible inhibitors, analogues of phosphoglycolate, the cofactor for this enzyme.The main routes involved an Arbuzov type reaction on functionalized halides, a reaction significantly improved by a sonication procedure and reaction of the diethylphosphite anion on tosylates.Phosphorylated epoxides were obtained by quantitative oxidation of conjugate double bonds using DMDO.Preliminary assays indicated a promising activity in some of these compounds.Keywords: phosphonates; inhibitors; phosphoglycerate Mutase; Arbuzov; DMDO